Browse studies

Find your next paid study

3,218 recruiting studies matching your filters

Phase Ib Expansion Study of CX-5461 in Patients With Solid Tumours and BRCA2 and/or PALB2 Mutation

This is an open-label, multi-center, phase 1b study designed to determine a tolerable dose of CX-5461 administered by IV infusion on Day 1 and Day 8 of a 28-da…

Advanced Solid Tumor

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Senhwa Biosciences, Inc.NCT04890613

Phase 3

Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer

This phase III trial compares the effect of adding stereotactic body radiation therapy (SBRT) to the usual treatment (conventional image guided radiation thera…

Locally Advanced Lung Non-Small Cell CarcinomaStage IIB Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8

Estimated

~$50 – $2,250

Actual pay is set by the research site.

NRG OncologyNCT05624996

Observational

Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

The purpose of this study is to examine the usefulness of implanting small 24-K gold fiducial markers around a bladder tumor site, so that a Radiation Oncologi…

Bladder CancerUrinary Bladder NeoplasmUrologic Neoplasms+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Cedars-Sinai Medical CenterNCT04442724

Observational

A Pilot Study of Spatially Fractionated Radiation Therapy in Patients With Extra-Cranial Soft Tissue Metastases

The purpose of this study is to find out whether lattice radiation therapy (LRT) is an effective radiation therapy technique when compared to standard stereota…

Invasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer Center

Phase 3

A Pivotal Registrational Phase 3 Study of Olverembatinib Combined With Chemotherapy Versus Investigator's Choice of TKI Combined With Chemotherapy in Patients With Newly Diagnosed Ph+ ALL

A global multicenter, open-label, randomized and registrational Phase 3 study to evaluate efficacy and safety of olverembatinib combined with chemotherapy vers…

Ph+ ALLLeukemia, Lymphoblastic, Acute, Philadelphia-Positive

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Ascentage Pharma Group Inc.NCT06051409

Phase 2

A Phase II Study of Lutetium Lu 177 Dotatate in Metastatic Prostate Cancer With Neuroendocrine Differentiation

This phase II trial studies how well lutetium Lu 177 dotatate works in treating patients with prostate cancer with neuroendocrine differentiation that has spre…

Metastatic Prostate Adenocarcinoma With Neuroendocrine DifferentiationMetastatic Prostate Neuroendocrine CarcinomaMetastatic Prostate Small Cell Neuroendocrine Carcinoma+1 more

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT05691465

Phase 1

Using Repetitive Transcranial Magnetic Stimulation to Manage Headaches and Improve Rehabilitation Outcomes in Mild Traumatic Brain Injury: A Longitudinal Study

This study aims to examine the long-term effect of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, on chronic …

Brain ConcussionMild Traumatic Brain InjuryHeadache+1 more

Estimated

~$500 – $7,500

Actual pay is set by the research site.

State University of New York - Upstate Medical UniversityNCT06112093

Phase 2

A Multicenter, Open-label, Randomized Phase 2 Study Evaluating Continuous Weekly Dosing of Ficerafusp Alfa (BCA101) in Combination With Pembrolizumab Versus an Alternative Ficerafusp Alfa Dosing Regimen for First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Ficerafusp alfa is directed against two targets, Epidermal Growth Factor Receptor (EGFR) and Transforming Growth Factor beta (TGF-β). The study aims to demons…

Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Bicara TherapeuticsNCT07807163

Observational

Transvaginal Detrusor Nerve Radiofrequency Ablation for Treatment of Overactive Bladder

The goal of this Safety and efficacy of transvaginal Detrusor Nerve Ablation for treatment of overactive bladder symptoms, including refractory overactive blad…

Overactive Bladder Syndrome

Estimated

~$10 – $1,050

Actual pay is set by the research site.

InMode MD Ltd.NCT06283498

Phase 1

A Phase 1 Study Evaluating the Safety, Tolerability, and Efficacy of BL-B01D1 in Subjects With Metastatic or Unresectable Non-Small Cell Lung Cancer and Other Solid Tumors

The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-B01D1 in patients with Metastatic or Unresectable Non-Small Cell Lung C…

Non Small Cell Lung CancerEsophageal CancerSmall Cell Lung Cancer+7 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

SystImmune Inc.NCT05983432

Observational

A Pilot Study of Partial Pleurectomy in Borderline and Unresectable Pleural Mesothelioma

Purpose of the study: The main purpose of this research study is to see if a surgery procedure (limited partial pleurectomy and decortication) helps symptoms i…

MesotheliomaMesothelioma; LungMesotheliomas Pleural+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of ChicagoNCT07126509

Phase 1

A Phase I/II, Open Label, Multi-center, Non-randomized Dose Escalation and Dose Expansion Study of AMXI-5001 in Patients With Advanced Malignancies

ATLAS-101 is a Phase I/II clinical trial of AMXI-5001 in adult participants with advanced malignancies who have previously failed other therapies. The study ha…

Advanced Malignant NeoplasmBreast CancerOvarian Cancer+3 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

AtlasMedx, IncorporatedNCT04503265